Atlas Trials

MT-R Followed by Autologous Stem Cells Transplantation in Newly-diagnosed Primary Central Nervous System Lymphoma

Clinical trial NCT02399189 · UNKNOWN

Trial details

NCT number
NCT02399189
Sponsor
Jun Zhu
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Primary Central Nervous System Lymphoma
Start date
2014-05-01
Primary completion
2017-04-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.